Brokerages Set Corteva, Inc. (NYSE:CTVA) PT at $81.84

Corteva, Inc. (NYSE:CTVA) has received a consensus rating of “Moderate Buy” from the twenty-two analysts that are currently covering the firm, MarketBeat.com reports. Seven equities research analysts have rated the stock with a hold recommendation, thirteen have issued a buy recommendation and two have given a strong buy recommendation to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $82.20.

A number of equities research analysts have issued reports on CTVA shares. Wall Street Zen lowered shares of Corteva from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. JPMorgan Chase & Co. lowered Corteva from an “overweight” rating to a “neutral” rating and upped their price objective for the stock from $75.00 to $77.00 in a research report on Thursday, February 5th. Deutsche Bank Aktiengesellschaft increased their price objective on Corteva from $85.00 to $90.00 and gave the company a “buy” rating in a research note on Thursday, February 5th. Bank of America boosted their target price on Corteva from $80.00 to $82.00 and gave the stock a “buy” rating in a research note on Thursday, January 8th. Finally, Rothschild & Co Redburn cut their price target on Corteva from $71.00 to $65.00 and set a “neutral” rating on the stock in a report on Tuesday, November 11th.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in CTVA. Gladwyn Financial Advisors Inc. acquired a new stake in shares of Corteva in the 2nd quarter valued at $25,000. Activest Wealth Management increased its holdings in Corteva by 118.3% in the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after buying an additional 200 shares during the last quarter. JPL Wealth Management LLC purchased a new position in Corteva in the third quarter valued at $25,000. True Wealth Design LLC raised its stake in Corteva by 209.5% in the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock valued at $26,000 after buying an additional 264 shares in the last quarter. Finally, Total Investment Management Inc. purchased a new stake in Corteva during the 2nd quarter worth about $27,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Stock Performance

Shares of Corteva stock opened at $73.99 on Friday. The business has a 50-day moving average of $69.49 and a 200 day moving average of $68.45. Corteva has a 12 month low of $53.40 and a 12 month high of $77.41. The stock has a market capitalization of $50.00 billion, a price-to-earnings ratio of 46.83, a price-to-earnings-growth ratio of 2.57 and a beta of 0.75. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The company had revenue of $3.91 billion for the quarter, compared to analyst estimates of $4.23 billion. During the same period in the prior year, the firm earned $0.32 earnings per share. The business’s revenue for the quarter was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, sell-side analysts forecast that Corteva will post 2.96 earnings per share for the current year.

Corteva Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be paid a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Monday, March 2nd. Corteva’s dividend payout ratio is presently 45.57%.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.